Clinical Trials
4 trialsNCT02711137 2025-10-21
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Phase 1/2 Terminated
NCT03878524 2024-03-04
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
OHSU Knight Cancer Institute
Phase 1 Terminated
NCT03919214 2023-04-19
Hypertension Management in Cancer Patients
Duke University
Phase NA Terminated
NCT02900248 2019-04-02
N1
CureOne
Terminated